Table 4

List of drugs or monoclonal antibodies which WHO has advised against, and the corresponding number of National Guidelines that (as a percentage of total) recommended these in late 2022

Drug or monoclonal antibodyIn late 2022, the number of NGs (%) recommending these medicines which WHO has advised against
Hydroxychloroquine or chloroquine19 (17%)
Favipiravir16 (15%)
Vitamins and/or zinc15 (14%)
Lopinavir–ritonavir14 (13%)
Azithromycin12 (11%)
Anakinra9 (8%)
Convalescent plasma or immunoglobulin9 (8%)
Interferons5 (5%)
Inhaled budesonide4 (4%)
  • NGs, national guidelines.